<DOC>
	<DOCNO>NCT00459628</DOCNO>
	<brief_summary>Tomotherapy new radiation therapy system use integrate CT scanner delivery radiation treatment improve accuracy treatment . Furthermore irradiation deliver helicoidally allow highly conformal shape dose distribution . However magnitude clinical advantage use system breast cancer unknown . The purpose present study investigate whether Tomotherapy substantially reduce pulmonary cardiac toxicity , compare conventional radiotherapy .</brief_summary>
	<brief_title>Trial Tomotherapy Breast Cancer</brief_title>
	<detailed_description>Prior surgery : histological confirmation ; medical imaging . Localizing marker place case breast conserving surgery . After surgery , patient randomize one two treatment arm : - Arm I : radiotherapy use tangential chest field , supraclavicular field case nodal involvement , accord hospital 's standard procedure ( Voordeckers M et al , Radiother Oncol 2003 ; 68:227 2004 ; 70:225 ) . Dose-fractionation : 50 Gy 25 fraction 5 week , 2 Gy/fraction . Additional boost 16 Gy 8 fraction 2 week breast conserve surgery ( verify marker/clip localization ) age &lt; = 70 year . - Arm II : radiotherapy use Tomotherapy system . Target area ( breast , thorax wall , nodal area ) delimit accord pre-operative imaging pathological description . Dose-fractionation ( adapt Whelan T et al , JNCI 2002 ; 94:1143 ) : 42 Gy 15 fraction 3 week , 2.8 Gy/fraction . Simultaneous boost 0.6 Gy/fraction breast conserving surgery . Physics quality control integrate treatment arm . Radiotherapy begin within 6 week last breast surgery . Concurrent sequential adjuvant systemic treatment allow . In case sequential adjuvant treatment chemotherapy first , radiotherapy begin within 6 week completion adjuvant chemotherapy . Quality life , arm mobility edema , pulmonary heart function assess prior radiotherapy , 1-3 month completion radiotherapy , yearly .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Informed consent Histologically proven breast carcinoma Stage I II ( T13N0 T12N1 M0 , AJCC/TNM 6th edition ) Surgery clear margin Preoperative medical imaging ( least CT , MRI , and/or PETscan ) Prior breast thoracic radiotherapy Pregnancy lactation Fertile patient without effective contraception Psychiatric addictive disorder</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>early breast cancer</keyword>
	<keyword>post-operative radiation treatment</keyword>
</DOC>